The compounding pharmacy debate is producing some strange bedfellows, with the drug industry and consumer advocacy group Public Citizen both calling for compounders to be regulated like drugmakers. The unlikely pair wants Congress to go beyond three current compounding bills discussed during a July 16 hearing of the House Energy & Commerce Committee Subcommittee on Health.
Washington Drug Letter
read here
Washington Drug Letter
read here
No comments:
Post a Comment